Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Liver cells donated for science: a new research goldmine?

NCT ID NCT00178893

Knowledge-focused Sponsor: Vanderbilt University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time

Summary

This study creates a registry of liver cells (hepatocytes) donated by people undergoing liver surgery for any reason. The goal is to collect and store these cells for use in future research. Participation involves donating a small sample of liver tissue during an already-scheduled operation. The registry aims to support scientific studies on liver health and disease.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this registry could provide a valuable resource for researchers studying liver function and diseases, potentially aiding future medical discoveries.
What could go wrong
This is a registry, not a treatment trial, so it offers no direct health benefit to participants. The usefulness depends on the quality and quantity of samples collected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

200 people

The number who actually took part.

Started

Apr 2004

Finished

Sep 2019

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Any patient having liver resection operation.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Persons undergoing partial hepatectomy/liver surgery for any reason. Exclusion Criteria: * Persons with known HIV, hepatitis B virus (HBV), or hepatitis C virus (HCV) * A diagnosis of hepatocellular carcinoma without negative serologies * A diagnosis of cholangiocarcinoma, where the total bilirubin has ever been greater or equal to 3.0 * The presence of a biliary drainage tube * Active sepsis

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hepatocytes are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hepatocytes

Contacts and locations

Locations

  • Vanderbilt University

    Nashville, Tennessee, 37232-4753, United States